You are the Program Manager, and you are trying to decide on the best course of action to decrease incidence and prevalence of the disease chosen in Week 1(Sickle Cell Anemia). You must decide from the data which population is most at-risk and decide on the most appropriate intervention to which you should allocate funds. To do this, you need to see the big picture. In this assignment, you will write a proposal (3-4 pages) to your Chief Executive Officer outlining the following:
- History of the disease (show trends and data)
- Needs assessment for your population:
- Social factors that may increase risk (poverty, health insurance, race/ethnicity, etc.)
- Morbidity and mortality data
- Incidence and prevalence data
- Suggested intervention program with cost analysis
- Justification and explanation for why this is the most appropriate intervention for the target population
How to Solve You are the Program Manager, and you are trying to decide on the best course of action to decrease incidence and prevalence of the disease chosen in Week 1(Sickle Cell Anemia). You must decide from th Nursing Assignment Help
Sickle Cell Anemia is a hereditary blood disorder that causes deformed and rigid red blood cells, leading to pain, anemia, and organ damage. The incidence and prevalence of this disease have been increasing in recent years, making it crucial to decrease its impact on the affected population. As a medical professor, I am designing an intervention program that aims to decrease the incidence and prevalence of Sickle Cell Anemia by identifying the most at-risk population and allocating funds to the most appropriate intervention.
History of the Disease:
Sickle Cell Anemia was first identified in 1910, and its genetic basis was uncovered in the 1940s. This disease affects people of African, Middle Eastern and Mediterranean descent but has been spreading to other populations in recent years due to genetic mixing. In the United States, approximately 100,000 people are affected, with 1 in 13 Black or African American babies born with the disease. It is estimated that 2 million individuals worldwide are affected each year.
Needs Assessment for the Population:
Demographics: The population most at-risk for Sickle Cell Anemia are individuals of African or Middle Eastern descent, with 1 in 365 African Americans and 1 in 16,300 Hispanic American births affected by the condition. However, as the disease continues to spread to other populations, we must ensure we consider all individuals when designing our intervention program.
Social Factors: Social determinants of health may increase the risk for Sickle Cell Anemia, with factors such as poverty, lack of health insurance, race, and ethnicity playing a role. Individuals from low-income families may not have access to adequate healthcare, leading to missed diagnoses and insufficient management of the disease.
Morbidity and Mortality Data: Morbidity and mortality rates associated with Sickle Cell Anemia are concerning, with patients experiencing pain crises, infections, organ damage, and premature death. In the United States, it is estimated that the annual economic impact of the disease is approximately $2 billion due to hospitalizations, outpatient visits, and lost productivity.
Incidence and Prevalence Data: The incidence and prevalence of Sickle Cell Anemia have been increasing in recent years, with a higher occurrence in individuals of African and Middle Eastern descent. Approximately 300,000 infants are born with Sickle Cell Anemia worldwide each year, with 80% of these occurring in sub-Saharan Africa.
Suggested Intervention Program with Cost Analysis:
Our intervention program will focus on increasing awareness about Sickle Cell Anemia, promoting early detection and management, providing genetic counseling, and improving healthcare access. The program will cost an estimated $10 million and will be funded through grants, insurance companies, and public health initiatives.
Justification and Explanation for Why This is the Most Appropriate Intervention for the Target Population:
The suggested intervention program is the most appropriate approach to decrease the incidence and prevalence of Sickle Cell Anemia in the target population. Early detection and management can lead to better patient outcomes and decreased morbidity and mortality rates. By increasing awareness and promoting education, individuals will be able to make informed decisions regarding their health and seek appropriate healthcare services. Furthermore, the provision of genetic counseling will enable individuals to better understand their risk of passing the disease to their offspring, leading to appropriate behavioral changes. Finally, improving healthcare access will ensure that individuals receive necessary treatments and reduce the burden of the disease on the economy.